Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -45.19%-846.86K | 88.87%-177.28K | -57.27%749.48K | 84.52%-295.39K | 89.00%-48.1K | 41.71%-583.27K | 46.03%-1.59M | 464.97%1.75M | -279.88%-1.91M | 69.32%-437.36K |
| Net income from continuing operations | -30.74%-586.86K | 32.71%-3.92M | 2.26%-1.99M | 62.07%-786.63K | 31.85%-689.96K | 35.67%-448.88K | -6.72%-5.82M | 23.39%-2.04M | -123.01%-2.07M | -6.69%-1.01M |
| Operating gains losses | ---- | --8.42K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -3.98%28.75K | -55.64%119.77K | -83.35%29.94K | -0.32%29.94K | -0.33%29.94K | -0.33%29.94K | 109.11%270K | 395.42%179.88K | -5.63%30.04K | -5.07%30.04K |
| Remuneration paid in stock | ---- | --0 | ---- | ---- | ---- | ---- | -58.61%216.2K | ---- | ---- | ---- |
| Other non cashItems | -2.84%61.69K | -85.63%69.18K | -286.98%-581.94K | 7,391.32%293.91K | 238.84%293.72K | -27.35%63.49K | 44.92%481.27K | 253.44%311.24K | -102.18%-4.03K | 210.22%86.68K |
| Change In working capital | -53.82%-350.44K | 8.59%3.54M | 3.47%3.29M | 238.77%167.39K | -30.58%318.21K | 45.79%-227.82K | 114.30%3.26M | 106.96%3.18M | -76.58%49.41K | 193.62%458.4K |
| -Change in receivables | -139.71%-44.23K | 4,175.24%131.51K | 23.35%-21.51K | 187.32%56.97K | -113.82%-15.34K | 632.16%111.39K | 92.86%-3.23K | 39.06%-28.07K | -2.37%-65.24K | -5.17%111.02K |
| -Change in inventory | ---- | --0 | --0 | --0 | --0 | --0 | 264.99%95.56K | 376.49%160.13K | --0 | --0 |
| -Change in prepaid assets | ---- | -86.60%34.9K | -95.84%34.9K | --0 | --0 | --0 | 374.70%260.4K | 380.22%839.18K | -14,467.70%-582.32K | 154.02%131.6K |
| -Change in payables and accrued expense | 9.73%-306.21K | 13.66%3.39M | 44.31%3.29M | -84.16%110.42K | 54.58%333.55K | -64.11%-339.21K | 77.34%2.98M | 55.53%2.28M | 157.48%696.98K | 159.43%215.78K |
| -Change in other working capital | ---- | 82.36%-12.67K | ---- | ---- | ---- | ---- | -284.63%-71.84K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -45.19%-846.86K | 88.87%-177.28K | -59.36%749.48K | 85.22%-295.39K | 89.00%-48.1K | 41.71%-583.27K | 46.03%-1.59M | 483.70%1.84M | -297.79%-2M | 70.56%-437.36K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 127.15%30.02K | 0 | 0 | |||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Net intangibles purchas and sale | ---- | ---- | ---- | --0 | --0 | --0 | --0 | 140.92%30.02K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | --0 | --0 | --0 | 127.15%30.02K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 87.98%810.61K | -108.54%-59.6K | 70.21%-838.61K | -87.24%396.79K | -114.50%-49.02K | 573.97%431.23K | -83.07%697.86K | -508.88%-2.81M | 150.27%3.11M | -80.99%337.98K |
| Net issuance payments of debt | 559.56%225.26K | 69.60%-59.6K | -60.54%89.17K | 84.34%-50.74K | 0.00%-49.02K | -0.00%-49.02K | -240.57%-196.07K | 125.18%225.98K | -126.07%-324.02K | 93.99%-49.02K |
| Net common stock issuance | 21.88%585.35K | --0 | 69.49%-927.78K | -86.97%447.53K | --0 | 325.00%480.25K | -78.61%893.93K | -291.75%-3.04M | 171,727,550.00%3.43M | -85.08%387K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---1 | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 87.98%810.61K | -108.54%-59.6K | 70.21%-838.61K | -87.24%396.79K | -114.50%-49.02K | 573.97%431.23K | -83.07%697.86K | -447.76%-2.81M | 177.27%3.11M | -79.77%337.98K |
| Net cash flow | ||||||||||
| Beginning cash position | -154.88%-83.94K | -85.40%152.94K | -99.52%5.2K | -420.07%-96.21K | -98.88%905 | -85.40%152.94K | --1.05M | 31.84%1.09M | -110.21%-18.5K | 311.58%80.87K |
| Current changes in cash | 76.16%-36.25K | 73.52%-236.88K | 90.52%-89.14K | -90.88%101.4K | 2.27%-97.11K | 84.27%-152.04K | -185.40%-894.62K | -531.03%-940.49K | 82.30%1.11M | -138.57%-99.37K |
| End cash Position | -13,380.55%-120.19K | -154.88%-83.94K | -154.88%-83.94K | -99.52%5.2K | -420.07%-96.21K | -98.88%905 | -85.40%152.94K | -85.40%152.94K | 31.84%1.09M | -110.21%-18.5K |
| Free cash from | -45.19%-846.86K | 88.87%-177.28K | -60.01%749.48K | 85.22%-295.39K | 89.00%-48.1K | 43.41%-583.27K | 48.20%-1.59M | 417.02%1.87M | -290.41%-2M | 70.63%-437.36K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.